Background: Asphyxia is one the most important causes of neonatal mortality and morbidity. It is suggested that magnesium may have a protective role against cellular damage during hypoxic brain insult, or change effect post-asphyxia consequences. Our study was performed for comparison of serum magnesium in neonates with and without asphyxia.
Introduction
Asphyxia is a medical condition in which embryonic hypoxia and hypercapnia occur due to the deprivation of oxygen to a newborn. This condition occurs during the first and the second phase of delivery which is recognized by embryonic acidosis (umbilical cord PH less than 7). Prenatal asphyxia is one of the most common causes of neonatal mortality. According to the available data, nearly 20% of neonatal mortality is due to prenatal asphyxia (1) . Asphyxia is characterized by signs of neonatal encephalopathy (hypotonia, declined neonatal reflexes, status of pupils and seizure), Apgar score < 4 at first and Apgar score < 7 at fifth minutes of birth and umbilical cord PH less than 7 (2) .
Prenatal asphyxia results in hypoxic damage in different body organs including kidneys, lungs and liver, but its most serious impact concerns the central nervous system (CNS). In the cellular level, hypoxic -ischemic damage results in a flood of a large number of biochemical changes which lead to cell death (3).
Magnesium is mainly an intra-cellular action, and very low amount of its total volume exists in extra-cellular space. Magnesium concentration remains stable within the narrow space of cell membrane by strong mechanisms of absorption and excretion of magnesium. In normal condition, magnesium exchange between intra-and extra-cellular space occurs slowly, whereas, in the ischemic condition, the speed of this exchange rises (4) .
Neonatal asphyxia leads to the production of high levels of glutamate amino acid in the brain. Within the first 72 hours, a large amount of glutamate causes irreversible neuronal damage by activating certain receptors and influx of calcium into neurons. Magnesium blocks these receptors and has a neuroprotective role which blocks the impact of asphyxia on different body organs (5).
Asphyxia may act as a risk factor of Intracranial hemorrhages (ICH) in term newborns although ICH is more common in preterm infants (6, 7) . Magnesium supplements have protective effects against neurologic complications of ICH in acutely ill neonates (8, 9) .
This study is designed to evaluate serum magnesium levels in neonates with asphyxia, and there was no study about this subject in Iran. Detection of hypomagnesemia in asphyxiated neonates will be the base of our future interventional studies in these high-risk infants.
Methods
Our research was a case-control study and performed in neonatal ward of Ali-Asghar children Hospital -tertiary and training center in Tehran, Iran-from January 2010 to January 2011.
The study was started after Ethical Committee of Iran University approved it (research code: 2248).The consent forms were filled by parents. During the study period, 152 neonates including 76 cases with a diagnosis of asphyxia and 76 normal newborns were compared.
Asphyxiated neonates were visited by a neonatologist in Akbarabadi Maternity Hospital and referred to our center. In Ali-Asghar NICU, patients were visited by second neonatologist and severity of asphyxia re-evaluated according to Sarnat and Sarnat classification. Perinatal asphyxia from the point of severity has three stages: In stage 1 there are mild encephalopathy, infant hyperalertness, dilated pupils and normal electroencephalography (EEG). Stage 2 includes moderate encephalopathy, hypotonia, lethargy, small pupils, seizures and abnormal EEG. In stage 3, there are severe encephalopathy, flaccidity, absence of reflexes, stupor, seizures and abnormal EEG with decreased background activity (1, 2) . Only cases with stage 2 asphyxia were enrolled in the study. Control cases were selected randomly from normal neonates with age of 3-5 days that examined in Ali-Asghar neonatal clinic as a routine care and matched for age and sex.
Exclusion criteria were defined as total parenteral nutrition (TPN), pre-eclampsia and magnesium sulfate therapy, prematurity, infants of diabetic mothers, neonatal systemic infections and metabolic disorders. During 24 hours after birth, 2 ml venous blood samples were taken. Blood specimens were collected and serum magnesium levels measured. Values of 1.5-2.3mg/dl as normal ranges of serum magnesium was considered. Data about gestational age, sex, and birth weight were recorded. The collected data was analyzed using 16 th version of statistical package for social sience (SPSS). Descriptive Statistical including frequency, mean and standard deviation and analytical statistics including Chi-square (qualitative variables comparison), t-test (quantitative variables comparison) and Odd ratios (at a confidence level of 95%) was calculated. P values less than 0.05 was considered significant.
Results
Among 152 neonates, 81(53.3%) were male. Mean gestational age was 37.9 ± 1.07 week (range 37 to 40 week). Mean birth weights were 3172.9±411.20 grams. Mean serum magnesium level was 1.89±0.32mg/dl.). Serum levels of magnesium in boys and girls didn't have significant difference (1.96±0.33mg/dl vs. 1.92±0.30mg/dl, p=0.8). Besides, no significant difference was seen between serum magnesium levels and gestational age and weight (p=0.8 and p=0.3). Mean serum magnesium level, gestational age, sex, and birth weight were compared in asphyxiated and normal neonates. The results was showed in Table 1 . There was a significant difference between serum magnesium levels of two mentioned groups (p=0.01). Twelve (16%) of neonates with asphyxia had hypomagnesemia. There was no case of hypomagnesemia in normal group (p=0.001).
The odds ratio was 2.188 with lower 1.826, upper 2.626 and confidence interval 95 percent which suggested a significant correlation between asphyxia and hypomagnesemia.
Discussion
Studies have shown some metabolic abnormalities in asphyxiated neonates including hypoglycemia, hyperammonemia, hypocalcemia and hypomagnesemia. Some of these disturbances lead to seizures and more brain injury (10, 11) .
Geven and Tsang's studies showed that asphyxia at birth leads to hypomagnesemia (5, 12). Jukarinen reported hypermagnesemia followed by asphyxia in their studies (13) . The underlying cause of these changes in total magnesium levels in asphyxiated neonates is not clear yet. Although in our study mean magnesium levels in asphyxiated cases was around 1.9 mg/dl, being in its normal range which cannot be interpreted as hypo or hypermagnesemia, hypomagnesemia was detected only in asphyxiated cases.
In a study conducted by Ilves et al, total magnesium concentration and ionized calcium in neonates with hypoxic-ischemic encephalopathy was evaluated. It was shown that asphyxiated neonates with or without signs of mild hypoxic-ischemic encephalopathy have higher total magnesium levels (0.81mmol /l=1.96mg/dl), while neonates with severe hypoxic-ischemic encephalopathy have lower total magnesium level (0.64mmol/l=1.55 mg/dl) in comparison with the control group (0.72mmol/l=1.75 mg/dl) (p<0.05) (3).
In a study designed by Bhat et al, 40 term asphyxiated neonates were examined and mean serum magnesium levels in asphyxiated cases was near to the result of our study. This similarity indicates that this number can be (4) . In the present study, serum magnesium levels in asphyxiated neonates were significantly lower than normal neonates and hypomagnesemia detected only in asphyxiated patients. In McIntosh et al. study, demonstrated that rapid decline of brain magnesium ions concentrations in rats occurs during hypoxic brain damage and can be correlated with severity of the injury. In their study, ATPMgCl 2 had a beneficial effect on neurological function (14) .
Hoffman et al. in an experimental study showed that activity of Na-K ATPase, as a marker of neuron membrane function, in asphyxiated cases decreases and leads to neuronal dysfunction. They tried magnesium sulfate after hypoxic injury and compared it with a control group. Upper levels of plasma magnesium increased mentioned marker and attenuated neuronal dysfunction (15) .
In Hossain et al. study, 50 neonates with moderate to severe hypoxic-Ischemic encephalopathy were divided into two groups. Mean serum magnesium levels was 1.6±0.3 and 1.8±0.4mg/dl in study and control groups. They received magnesium sulfate and normal saline respectively. Neurological abnormalities were detected in 26% of experimental cases and 61% of control group. They demonstrated that magnesium infusion improves short outcome in neonatal asphyxia (16) .
In our study, no severe case of asphyxia was seen which might be due to our limitations such as small sample size, or since this hospital is a referral center with no nearby maternity center, less severe cases (with transferring possibility) were admitted.
Conclusion
Asphyxia can lead to hypomagnesemia, and it is recommended to evaluate levels of magnesium in neonates with asphyxia as a routine test and treat properly any case with decreased serum level of magnesium.
